FGF23: Clinical usefulness and analytical evolution

Clin Biochem. 2019 Apr:66:1-12. doi: 10.1016/j.clinbiochem.2019.03.002. Epub 2019 Mar 7.

Abstract

Fibroblast Growth Factor 23 (FGF23) is a key hormone for the regulation of phosphate homeostasis. Over the past decades, FGF23 was the subject of intense research in the fields of nephrology and the cardiology. It presents a remarkable correlation with well-established biomarkers of cardiovascular disorders in both chronic kidney disease (CKD) and heart failure (HF) patients. The interest of FGF23 lies in its early-onset in the primary course of CKD as well as in the incremental prognosis information it conveys in both CKD and HF. Different types of assays of FGF-23 testing exist, those targeting the intact form (iFGF23), the other one detecting terminal fragments (cFGF23). The issue is still pending which assay suits best for clinical use. Recently, the implementation of this biomarker on multianalyzer platforms, on which other markers of phospho-calcic balance are set up, allows a rapid turn-around-time and a potential financial gain. However, despite the good analytical performances of the automated methods, there is a poor harmonization between assays. The introduction of an international certified reference material should standardize the measurement and improve the harmonization of results from different laboratories. A deeper understanding of physio-pathological mechanisms and processing of FGF-23 should reinforce its clinical indications and might also identify new therapeutic targets for the treatment of CKD and HF.

Keywords: Biomarker; Cardiovascular risk; FGF23; Heart failure; Kidney diseases; Klotho; Phosphate.

Publication types

  • Review

MeSH terms

  • Animals
  • Biomarkers / analysis
  • Biomarkers / metabolism
  • Female
  • Fibroblast Growth Factor-23
  • Fibroblast Growth Factors / analysis*
  • Fibroblast Growth Factors / metabolism
  • Heart Failure / diagnosis*
  • Humans
  • Male
  • Prognosis
  • Renal Insufficiency, Chronic / diagnosis*

Substances

  • Biomarkers
  • FGF23 protein, human
  • Fibroblast Growth Factors
  • Fibroblast Growth Factor-23